Zoetis Work in process increased by 11.8% to $1.11B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 9.9%, from $1.01B to $1.11B. Over 5 years (FY 2020 to FY 2025), Work in process shows an upward trend with a 10.8% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase may indicate production bottlenecks or scaling efforts, while a decrease suggests efficient throughput or reduced manufacturing activity.
Represents the value of goods that have entered the production process but are not yet finished. For a manufacturer like...
Peers in medical device manufacturing typically maintain lean WIP levels to optimize cash conversion cycles.
inv_work_in_progress| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $657.00M | $675.00M | $696.00M | $764.00M | $791.00M | $830.00M | $825.00M | $999.00M | $1.07B | $1.06B | $966.00M | $1.05B | $953.00M | $951.00M | $933.00M | $1.01B | $1.03B | $1.04B | $991.00M | $1.11B |
| QoQ Change | — | +2.7% | +3.1% | +9.8% | +3.5% | +4.9% | -0.6% | +21.1% | +7.5% | -1.1% | -9.0% | +8.8% | -9.3% | -0.2% | -1.9% | +8.0% | +1.9% | +1.0% | -4.4% | +11.8% |
| YoY Change | — | — | — | — | +20.4% | +23.0% | +18.5% | +30.8% | +35.8% | +28.0% | +17.1% | +5.2% | -11.3% | -10.5% | -3.4% | -4.1% | +7.8% | +9.0% | +6.2% | +9.9% |
| % of Inventories | 36.5% | 36.0% | 36.2% | 37.1% | 35.9% | 36.0% | 35.2% | 39.0% | 39.8% | 38.7% | 37.7% | 39.6% | 38.9% | 39.4% | 40.5% | 42.6% | 42.1% | 42.1% | 40.2% | 43.5% |
| Share Change | — | -0.5pp | +0.2pp | +0.9pp | -1.3pp | +0.2pp | -0.9pp | +3.8pp | +0.8pp | -1.1pp | -1.0pp | +2.0pp | -0.8pp | +0.5pp | +1.1pp | +2.2pp | -0.5pp | -0.0pp | -1.8pp | +3.2pp |